FDA orphan drug designation: prevention of organ rejection in patients receiving a liver transplant
All entries for: Veloxis Pharmaceuticals
December 23, 2025
Veloxis Pharmaceuticals
Orphan Drug Designation
Disease Area: Rare Diseases